1. Home
  2. KNSA vs OII Comparison

KNSA vs OII Comparison

Compare KNSA & OII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • OII
  • Stock Information
  • Founded
  • KNSA 2015
  • OII 1964
  • Country
  • KNSA United Kingdom
  • OII United States
  • Employees
  • KNSA N/A
  • OII N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • OII Oilfield Services/Equipment
  • Sector
  • KNSA Health Care
  • OII Energy
  • Exchange
  • KNSA Nasdaq
  • OII Nasdaq
  • Market Cap
  • KNSA 2.1B
  • OII 2.1B
  • IPO Year
  • KNSA 2018
  • OII N/A
  • Fundamental
  • Price
  • KNSA $27.12
  • OII $22.44
  • Analyst Decision
  • KNSA Strong Buy
  • OII Hold
  • Analyst Count
  • KNSA 6
  • OII 5
  • Target Price
  • KNSA $39.33
  • OII $28.00
  • AVG Volume (30 Days)
  • KNSA 980.0K
  • OII 783.1K
  • Earning Date
  • KNSA 07-29-2025
  • OII 07-23-2025
  • Dividend Yield
  • KNSA N/A
  • OII N/A
  • EPS Growth
  • KNSA N/A
  • OII 67.93
  • EPS
  • KNSA N/A
  • OII 1.78
  • Revenue
  • KNSA $481,166,000.00
  • OII $2,736,592,000.00
  • Revenue This Year
  • KNSA $37.21
  • OII $4.92
  • Revenue Next Year
  • KNSA $5.32
  • OII $3.22
  • P/E Ratio
  • KNSA N/A
  • OII $12.61
  • Revenue Growth
  • KNSA 59.45
  • OII 10.04
  • 52 Week Low
  • KNSA $17.82
  • OII $15.46
  • 52 Week High
  • KNSA $30.69
  • OII $30.98
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 43.14
  • OII 64.24
  • Support Level
  • KNSA $28.19
  • OII $20.21
  • Resistance Level
  • KNSA $29.58
  • OII $21.07
  • Average True Range (ATR)
  • KNSA 0.93
  • OII 0.68
  • MACD
  • KNSA -0.13
  • OII 0.01
  • Stochastic Oscillator
  • KNSA 3.15
  • OII 94.09

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

Share on Social Networks: